Breaking News Instant updates and real-time market news.

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44

Xilinx downgraded to Hold from Buy at Needham

Needham analyst N. Quinn Bolton downgraded Xilinx to Hold after its Q4 results, saying that while the quarter was "in-line to slightly better", the gross margin guidance for Q1 was "well below" consensus. The analyst adds that although he is impressed with growth in the company's Comms business, he sees a risk to multiple compression on the stock from deceleration in Wireless Comms and the possibility of delayed 5G deployments outside of Korea.

  • 14

    May

XLNX Xilinx
$139.79

2.66 (1.94%)

04/22/19
MSCO
04/22/19
NO CHANGE
Target $137
MSCO
Overweight
Xilinx price target raised to $137 from $101 at Morgan Stanley
Morgan Stanley analyst Joseph Moore said Xilinx stands to benefit as wireless carriers prepare to introduce 5G service in the second half of 2019 and 2020, stating that the overall FPGA total available market is expanding substantially for 5G vs. LTE because of the need to build out newly integrated massive MIMO, or "mMIMO," antenna systems. Additionally, his checks show Xilinx has much higher market share in 5G vs. LTE, Moore noted. Stating that he does not think that 5G is the primary reason to own Xilinx, Moore added that he doesn't think that it is peaking either. He raised his price target on Xilinx shares to $137 from $101 and keeps an Overweight rating on the stock.
04/25/19
GSCO
04/25/19
DOWNGRADE
Target $122
GSCO
Neutral
Xilinx downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Toshiya Hari downgraded Xilinx to Neutral from Buy with an unchanged price target of $122. The company's long-term thesis remains intact following yesterday's fiscal Q4 results but the stock's valuation is now full, Hari tells investors in a research note. The analyst adds that an elongated spending cycle in 5G or increased market share in datacenter/automotive would make him more constructive on Xilinx shares.
04/25/19
MKMP
04/25/19
NO CHANGE
Target $120
MKMP
Neutral
Xilinx price target raised to $120 from $95 at MKM Partners
MKM Partners analyst Ruben Roy raised his price target on Xilinx to $120 after its Q4 results that saw a 4% sequential and 30% annualized increase in revenue, even though its gross margin of 67.5% was a point below prior guidance. The analyst states that the outlook for Q1 was above consensus, but believes that expectations were "likely higher", with the stock down over 8% in the pre-market. Roy is keeping his Neutral rating on Xilinx, forecasting its revenue growth to "remain muted" going into the September quarter against a slight increase in operating expenses.
04/25/19
NEED
04/25/19
DOWNGRADE
NEED
Hold
Xilinx downgraded to Hold from Buy at Needham

TODAY'S FREE FLY STORIES

TPX

Tempur Sealy

$74.38

0.95 (1.29%)

, BIG

Big Lots

$28.98

-0.375 (-1.28%)

07:30
06/24/19
06/24
07:30
06/24/19
07:30
Upgrade
Tempur Sealy, Big Lots rating change  »

Tempur Sealy upgraded to…

TPX

Tempur Sealy

$74.38

0.95 (1.29%)

BIG

Big Lots

$28.98

-0.375 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOP

GasLog Partners

$21.49

0.09 (0.42%)

, GLOG

GasLog

$13.36

-0.02 (-0.15%)

07:30
06/24/19
06/24
07:30
06/24/19
07:30
Hot Stocks
GasLog, GasLog Partners agree to eliminate incentive distribution rights »

GasLog (GLOG) and GasLog…

GLOP

GasLog Partners

$21.49

0.09 (0.42%)

GLOG

GasLog

$13.36

-0.02 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:30
06/24/19
06/24
07:30
06/24/19
07:30
General news
Treasury Market Outlook: bonds have caught a bid »

Treasury Market Outlook:…

TRLFF

True Leaf Medicine

$0.00

(0.00%)

, NXTTF

Namaste Technologies

$0.00

(0.00%)

07:27
06/24/19
06/24
07:27
06/24/19
07:27
Hot Stocks
True Leaf Medicine announces supply agreement with Namaste Technologies »

True Leaf Brands (TRLFF)…

TRLFF

True Leaf Medicine

$0.00

(0.00%)

NXTTF

Namaste Technologies

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARLP

Alliance Resource Partners

$16.96

-0.12 (-0.70%)

07:27
06/24/19
06/24
07:27
06/24/19
07:27
Hot Stocks
Alliance Resource Partners to acquire $145M of Permian Basin interests »

Alliance Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNET

RigNet

$8.64

0.22 (2.61%)

, IMASY

Inmarsat

$0.00

(0.00%)

07:25
06/24/19
06/24
07:25
06/24/19
07:25
Hot Stocks
RigNet announces settlement of Inmarsat arbitration »

RigNet (RNET) announced…

RNET

RigNet

$8.64

0.22 (2.61%)

IMASY

Inmarsat

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$76.12

-0.82 (-1.07%)

07:23
06/24/19
06/24
07:23
06/24/19
07:23
Upgrade
Fortinet rating change  »

Fortinet upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

POST

Post Holdings

$104.28

0.075 (0.07%)

07:23
06/24/19
06/24
07:23
06/24/19
07:23
Hot Stocks
Post Holdings narrows FY19 adjusted EBITDA view $1.2B-$1.22B from $1.2B-$1.24B »

Post Holdings provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMUX

Immunic

$9.71

0.04 (0.41%)

07:23
06/24/19
06/24
07:23
06/24/19
07:23
Hot Stocks
Immunic to present unpublished IMU-838 data at GIIDS »

Immunic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

PSTI

Pluristem

$0.57

-0.0142 (-2.43%)

07:21
06/24/19
06/24
07:21
06/24/19
07:21
Hot Stocks
Pluristem appoints Yaky Yanay as sole CEO »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFNX

Pfenex

$6.57

-0.19 (-2.81%)

07:20
06/24/19
06/24
07:20
06/24/19
07:20
Conference/Events
Pfenex management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 07

    Oct

INNT

Innovate Biopharmaceuticals

$1.23

-0.025 (-2.00%)

, CGIX

Cancer Genetics

$0.17

-0.0033 (-1.89%)

07:20
06/24/19
06/24
07:20
06/24/19
07:20
Hot Stocks
Innovate Biopharmaceuticals appoints ED Sitar as CFO »

Innovate…

INNT

Innovate Biopharmaceuticals

$1.23

-0.025 (-2.00%)

CGIX

Cancer Genetics

$0.17

-0.0033 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$57.07

-0.54 (-0.94%)

07:18
06/24/19
06/24
07:18
06/24/19
07:18
Conference/Events
NuVasive management to meet with BTIG »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:15
06/24/19
06/24
07:15
06/24/19
07:15
General news
FX Update: The dollar has started the week on a soft footing »

FX Update: The dollar has…

DAN

Dana

$17.94

0.05 (0.28%)

07:14
06/24/19
06/24
07:14
06/24/19
07:14
Hot Stocks
Dana announces reduction of pension liabilities »

Dana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTRN

Materion

$67.06

-0.54 (-0.80%)

07:14
06/24/19
06/24
07:14
06/24/19
07:14
Conference/Events
Materion management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 25

    Sep

CGC

Canopy Growth

$40.20

-3.495 (-8.00%)

07:13
06/24/19
06/24
07:13
06/24/19
07:13
Hot Stocks
Canopy Growth adds substantial production capacity in Canada »

Canopy Growth is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$32.46

0.58 (1.82%)

07:12
06/24/19
06/24
07:12
06/24/19
07:12
Conference/Events
MPLX management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

MDR

McDermott

$8.35

0.14 (1.71%)

07:12
06/24/19
06/24
07:12
06/24/19
07:12
Hot Stocks
McDermott awarded large offshore EPCI contract from Saudi Aramco »

McDermott announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$29.98

0.2 (0.67%)

07:10
06/24/19
06/24
07:10
06/24/19
07:10
Hot Stocks
Axalta Coating announces Chairman Charlie Shaver resigns, Mark Garrett succeeds »

Axalta Coating announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORV

Correvio

$2.27

-0.13 (-5.42%)

07:09
06/24/19
06/24
07:09
06/24/19
07:09
Hot Stocks
Correvio resubmits Brinavess NDA to FDA »

Correvio announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

07:07
06/24/19
06/24
07:07
06/24/19
07:07
Hot Stocks
Bristol-Myers: CheckMate -459 study did not reach pre-specified primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 16

    Sep

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

, CELG

Celgene

$98.92

0.75 (0.76%)

07:05
06/24/19
06/24
07:05
06/24/19
07:05
Hot Stocks
Bristol-Myers plans Otezla sale to get FTC Celgene clearance »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

CELG

Celgene

$98.92

0.75 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

, CELG

Celgene

$98.92

0.75 (0.76%)

07:03
06/24/19
06/24
07:03
06/24/19
07:03
Hot Stocks
Breaking Hot Stocks news story on Bristol-Myers, Celgene »

Bristol-Myers plans…

BMY

Bristol-Myers

$49.36

0.46 (0.94%)

CELG

Celgene

$98.92

0.75 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ATNX

Athenex

$17.95

-0.06 (-0.33%)

07:02
06/24/19
06/24
07:02
06/24/19
07:02
Hot Stocks
Athenex announces FDA allowance of IND application for PT01 »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.